Tumor Associated Macrophages: The Double-Edged Sword Resolved? Writer/Curator: Stephen J. Williams, Ph.D. Cell-based immunity is vital for our defense against pathologic insult but recent evidence has shown the role of cell-based immunity, especially macrophages to play an important role in both the development and hindrance of tumor growth, including role in ovarian, hematologic cancers, melanoma, […]
Search Results for 'double edged'
Tumor Associated Macrophages: The Double-Edged Sword Resolved?
Posted in Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Immuno-Oncology & Genomics, tagged Adaptive immune system, Biology, breast cancer, Cancer - General, Cancer immunology, Cell Biology, Conditions and Diseases, gene expression, genomics, macrophages, modulation of tumor tolerance, research, Stem cell, tumor associated macrophage, tumor microenvironment, Weill Cornell on September 15, 2015| 3 Comments »
Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin
Posted in Biological Networks, Gene Regulation and Evolution, Genome Biology, Interviews with Scientific Leaders, tagged DNA, Double Helix, Francis Crick, James D. Watson, Maurice Wilkins, Rosalind Franklin on November 9, 2012| 8 Comments »
Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin Curator: Aviva Lev-Ari, PhD. RN As a new edition of The Double Helix hits bookshelves, Boing-Boing‘s Maggie Koerth-Baker takes the opportunity to interview James Watson about his characterization of Rosalind Franklin, who, Koerth-Baker says, “is unfairly maligned in […]
Voices of Global Citizens: Impact of The Coronavirus Pandemic Gail S. Thornton, M.A. Richard A. Mandahl, MBA and Sudipta Saha, PhD Lead Curators – e–mail Contacts: gailsthornton@yahoo.com and rmandahl@gmail.com and sudiptasaha1977@gmail.com
Posted in on March 18, 2020|
Voices of Global Citizens: Impact of The Coronavirus Pandemic Gail S. Thornton, M.A. Richard A. Mandahl, MBA and Sudipta Saha, PhD Lead Curators – e–mail Contacts: gailsthornton@yahoo.com and rmandahl@gmail.com and sudiptasaha1977@gmail.com Voices of Patients Tested Positive to Coronavirus Infections in the US Voices of Nurses and Allied Health Care Professionals in the US in the Coronavirus Pandemic Voices of Physicians at Hospitals Caring for Coronavirus Pandemic Voices […]
Expedite Use of Agents in Clinical Trials: New Drug Formulary Created – The NCI Formulary is a public-private partnership between NCI, part of the National Institutes of Health, and pharmaceutical and biotechnology companies
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Pharmaceutical Drug Discovery, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Informatics, Pharmaceutical R&D Investment, Pharmacodynamics and Pharmacokinetics, The NCI Formulary on January 12, 2017| Leave a Comment »
Expedite Use of Agents in Clinical Trials: New Drug Formulary Created – The NCI Formulary is a public-private partnership between NCI, part of the National Institutes of Health, and pharmaceutical and biotechnology companies Reporter: Aviva Lev-Ari, PhD, RN Wednesday, January 11, 2017 New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials istock/Astakhova […]
Oncolytic Virotherapy for Pancreatic Cancer: Overcoming Obstacles in Oncolytic Virus Delivery
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Immuno-Oncology & Genomics on July 24, 2016| Leave a Comment »
Oncolytic Virotherapy for Pancreatic Cancer: Overcoming Obstacles in Oncolytic Virus Delivery Reporter: Aviva Lev-Ari, PhD, RN We covered MGH’s Innovation on Tumor targeted therapy in Pancreatic Cancer in Pancreatic Cancer Targeted Treatment? Curator: Larry H. Bernstein, MD, FCAP https://pharmaceuticalintelligence.com/2016/05/18/pancreatic-cancer-targeted-treatment/ Below, we report on the State of the Science for Overcoming Obstacles in Oncolytic Virus […]
Oncolytic Virus Immuno-Therapy: New Approach for a New Class of Immunotherapy Drugs
Posted in Immunology, Immunotherapy, Innovation in Immunology Diagnostics, Innovations, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Virology, tagged adaptive, Clinical trial, immune response, Immunotherapy, innate, Oncolytic virus & OncoViro-Therapy on April 12, 2016| Leave a Comment »
Oncolytic Virus Immuno-Therapy: New Approach for a New Class of Immunotherapy Drugs Curator: Larry H. Bernstein, MD, FCAP Oncolytic viruses represent a promising novel immunotherapy strategy, which may be optimally combined with existing therapeutic modalities Oncolytic viruses: a novel form of immunotherapy Robin J Prestwich, Kevin J Harrington, Hardev S Pandha, Richard G Vile, Alan […]
Schizophrenia genomics
Posted in Genome Biology, Mutant Gene Expression, Neurological Diseases, Neuroscience, Schizophrenia, tagged Akt/PKB, autism spectrum disorders (ASDs), Chromatin, copy number variation (CNV), Epigenetics, histone methylation, Lymphocyte, methyl-CpG-binding domain (MBD), PDK2, PI3K/PTEN, Postmortem Brain, Rett syndrome, Schizophrenia, single nucleotide polymorphism (SNP) on March 15, 2016| Leave a Comment »
Schizophrenia genomics Larry H. Bernstein, MD, FCAP, Curator LPBI Histone Methylation at H3K9; Evidence for a Restrictive Epigenome in Schizophrenia Kayla A. Chase,1David P. Gavin,1Alessandro Guidotti,1 and Rajiv P. Sharma1 Schizophr Res. 2013 Sep; 149(0): 15–20. doi: 10.1016/j.schres.2013.06.021 Epigenetic changes are stable and long-lasting chromatin modifications that regulate genomewide and local gene activity. […]
-
Recent Posts
- RNA from the SARS-CoV-2 virus taking over the cells it infects: Virulence – Pathogen’s ability to infect a Resistant Host: The Imbalance between Controlling virus Replication versus Activation of the Adaptive Immune Response May 23, 2020
- UPDATED Is Remdesivir the miracle cure or a short term cure for COVID-19? May 22, 2020
- Australian Children’s Hospital: SARS-CoV-2 Testing May 20, 2020
- A Series of Recently Published Papers Report the Development of SARS-CoV2 Neutralizing Antibodies and Passive Immunity toward COVID19 May 19, 2020
- The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership on May 18, 2020 May 18, 2020
- Race to develop antibody drugs for COVID-19 May 18, 2020
- Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats May 17, 2020
- The COVID-19 Recovery will be digital: A plan for the First 90 Days May 16, 2020
- Crowdsourcing Difficult-to-Collect Epidemiological Data in Pandemics: Lessons from Ebola to the current COVID-19 Pandemic May 15, 2020
- The Seasonality of COVID-19 May 15, 2020
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
ofermar2020
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
